Menu
← Oncology Approval Tracker
FDA DECISION ·
Xtandi tablets
enzalutamide · Astellas Pharma
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
An oral tablet formulation for patients with castration-resistant prostate cancer or metastatic castration-sensitive prostate cancer.
LAMPGEN ANALYSIS
Why it matters
Added tablets as another dosage form for established enzalutamide indications.
What research teams should watch
Specify dosage form and strength in orders and reconcile androgen deprivation therapy.
PRIMARY RECORDS